CytoDyn Inc. (CYDY) › Operating Cash FlowCytoDyn Inc. (CYDY) — Operating Cash FlowAnnual figures by fiscal year, from SEC filings.2011: -$1.82M2012: -$4.39M2013: -$3.39M2014: -$7.39M2016: -$24.81M2017: -$26.73M2018: -$29.90M2019: -$50.47M2020: -$68.80M2021: -$117.57M2022: -$77.72M2023: -$25.11M2024: -$10.98M2025: -$8.77M-$8.77M2011Operating Cash Flow (USD)2025Fiscal YearOperating Cash FlowChange YoY2025-$8.77M+20.2%2024-$10.98M+56.3%2023-$25.11M+67.7%2022-$77.72M+33.9%2021-$117.57M-70.9%2020-$68.80M-36.3%2019-$50.47M-68.8%2018-$29.90M-11.8%2017-$26.73M-7.7%2016-$24.81M—2014-$7.39M-117.7%2013-$3.39M+22.7%2012-$4.39M-141.1%2011-$1.82M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsCapital ExpendituresShares OutstandingDividends Per Share